2seventy bio, Inc. logo

2seventy bio, Inc.

NASDAQ:TSVT

Overview | Financials
Company Name 2seventy bio, Inc.
Symbol TSVT
Currency USD
Price 4.98
Market Cap 260,645,147
Dividend Yield 0%
52-week-range 2.29 - 5.3
Industry Biotechnology
Sector Healthcare
CEO Mr. Nick Leschly
Website https://www.2seventybio.com

An error occurred while fetching data.

About 2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has

Related Stocks

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

0.758 USD

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

4.95 USD

Immatics N.V. logo

Immatics N.V.

IMTX

4.26 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

6.17 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

10.53 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

5.32 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

15.15 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

4.755 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

21.29 USD

Financials

Numbers are in millions USD

Numbers are in millions USD